There are 2867 resources available
523MO - Ubamatamab (REGN4018, MUC16xCD3 bispecific antibody) monotherapy in patients with recurrent ovarian cancer (OC): Phase I dose-escalation analysis
Presenter: David O'Malley
Session: Mini Oral session 1: Gynaecological cancers
Resources:
Abstract
Slides
Webcast
524MO - Glucocorticoid receptor expression and activity in a phase II ovarian cancer trial of the glucocorticoid receptor modulator relacorilant in combination with nab-paclitaxel
Presenter: Domenica Lorusso
Session: Mini Oral session 1: Gynaecological cancers
Resources:
Abstract
Slides
Webcast
Invited Discussant 523MO and 524MO
Presenter: Iain McNeish
Session: Mini Oral session 1: Gynaecological cancers
Resources:
Slides
Webcast
1393P - Comparison of genomic alterations (GA) landscape in SPOP mutated (SPOPmut) and SPOP wild type (SPOPwt) clinically advanced prostate cancer (CAPC)
Presenter: Gennady Bratslavsky
Session: Poster session 11
299P - Integrative analysis of longitudinal genomic and non-genetic mechanisms of radiotherapy resistance
Presenter: Emre Kocakavuk
Session: Poster session 03
1050P - Association of ctDNA quantification with prognosis and early prediction of response to first-line osimertinib in NSCLC patients
Presenter: Marc Denis
Session: Poster session 15
Introduction by the Chair
Presenter: Marleen Kok
Session: Does hyperprogression exist?
Resources:
Slides
Webcast
Presentation of case/condition
Presenter: Alfredo Berruti
Session: Management of adrenocortical carcinoma
Resources:
Slides
Webcast
Presentation by Expert
Presenter: Alessandro Gronchi
Session: Can we cure oligometastatic disease in sarcoma patients?
Resources:
Slides
Webcast
Presentation by Expert
Presenter: Nathan Cherny
Session: What every oncologist should know about palliative sedation?
Resources:
Slides
Webcast